Study of Hepatitis C Genotypes in Brazil
Author Information
Author(s): Aline G Vigani, Maria H Pavan, Raquel Tozzo, Eduardo SL Gonçales, Adriana Feltrin, Viviane C Fais, Maria SK Lazarini, Neiva SL Gonçales, Fernando L Gonçales Jr
Primary Institution: Universidade Estadual de Campinas – UNICAMP
Hypothesis
The association between specific HCV genotype and clinical outcome remains unclear.
Conclusion
Genotype 3 is associated with intravenous drug use, high frequency of cryoglobulinemia, and advanced liver disease in the region studied.
Supporting Evidence
- Genotype 1 was identified in 57.6% of patients, while genotype 3 was found in 39.6%.
- Intravenous drug use was significantly associated with genotype 3 infections.
- Patients with genotype 3 had higher levels of ALT and AST compared to those with genotype 1.
- Cryoglobulinemia was more frequent among patients infected with genotype 3.
Takeaway
This study looked at how different types of hepatitis C virus affect people's health, finding that one type is linked to more serious health problems.
Methodology
Patients with HCV infection referred for treatment were included, and data were collected on their epidemiological, clinical, and laboratory characteristics.
Limitations
The study could not account for factors like dose reduction and race, which are important predictors for treatment response.
Participant Demographics
The median age was 43 years, with 73% of participants being men.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI = 1.0–3.7
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website